GSK, Pennsylvania
GSK embarks on Pennsylvania manufacturing expansion worth up to $800M, creating 200 new jobs
After making a splash in the U.K. earlier this year, GSK is laying out plans for its biggest U.S. manufacturing investment yet. | In its biggest U.S. manufacturing investment yet, GSK is spending up to $800 million to double the size and capacity of its site in Marietta,
GSK (GSK) continued losses for a seventh straight session as the stock closed xx% lower, at $xx on Friday. The British ...
The British pharma is making what it calls its largest U.S. manufacturing investment. Elsewhere, AbbVie expanded a ...
GSK plans to invest $800 million in its East Donegal Township vaccine packaging facility over the next four years in an ...
Haleon was spun off from GSK amid investor pressure, showing steady growth but facing debt concerns. See more about HLN stock ...
GlobalData on MSN2d
GSK pumps up to $800m for US manufacturing site upgradeA new vaccines drug substance facility and R&D pilot plant, completed by the end of 2028, will create over 200 new jobs.
Shares of GSK PLC GSK inched up 0.52% to £14.56 Thursday, on what proved to be an all-around positive trading session for ...
GSK Plc’s experimental drug to treat a common inflammatory nasal condition showed positive results in two late-stage trials ...
Pharma with 3,674 puts trading, or 5x expected. Most active are 10/25 weekly 38 puts and Nov-24 40 calls, with ...
Shares of GSK PLC GSK inched down 0.72% to £14.54 Tuesday, on what proved to be an all-around dismal trading session for ...
GSK said it is making its largest manufacturing investment in the US yet, allocating $800 million to upgrade its vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback